SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-115756
Filing Date
2009-05-20
Accepted
2009-05-20 16:18:52
Documents
2
Period of Report
2009-05-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 17090
2 ENGLISH TRANSLATION OF SEVERANCE AGREEMENT dex101.htm EX-10.1 46679
  Complete submission text file 0001193125-09-115756.txt   65366
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 09842761
SIC: 2834 Pharmaceutical Preparations